- About Us
- Customized Drug Release
- Bioavailability Enhancement
- Products for Out-Licensing
- Events & Publications
Our owned and in-licensed patent portfolio consists of over 900 granted patents and pending applications.
This portfolio is composed of patents with claims directed to our formulation technologies and related materials, processes, equipment and methods of manufacture. We also have many product-related patents, which contain more specific claims directed to particular drugs or classes of drugs in combination with our formulation technology.
Aptalis Pharmaceutical Technologies endeavors to offer the most effective patent protection possible to our partners based on our broad and diversified portfolio of Pharmaceutical Technologies.
Aptalis Pharmaceutical Technologies has registered, and/or pending applications for the registration of, certain trademarks in various countries, which allow the company to create brand recognition of our technologies and enhance loyalty within our customer base.